BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9810173)

  • 1. Lauren's and Goseki's grade distribution does not change along with the progression from an early to advanced gastric carcinoma.
    Stachura J; Popiela T; Kulig J; Urbańczyk K; Heitzman J
    Pol J Pathol; 1998; 49(3):151-3. PubMed ID: 9810173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III.
    Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M
    Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of histologic classifications of advanced stomach cancer: comparative study of Lauren's and Goseki's classifications].
    Guglielmi A; de Manzoni G; Tomezzoli A; Ricci F; Pelosi G; Laterza E; Di Leo A; Bonfiglio M
    Chir Ital; 1997; 49(3):45-9. PubMed ID: 9612652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do gastric carcinoma classification systems relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas.
    Gürbüz Y; Kahlke V; Klöppel G
    Virchows Arch; 2002 May; 440(5):505-11. PubMed ID: 12021925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric cancer: correlation between clinicopathological factors and survival of patients. II.
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(2):185-94. PubMed ID: 19434309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of prognostic significance in Goseki grading of gastric carcinoma.
    Ventura L; Chiominto A; Discepoli S; Ventura T; Di Giacomo C; Leocata P
    J Exp Clin Cancer Res; 2002 Jun; 21(2):225-7. PubMed ID: 12148582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Correlation of histological classifications of gastric carcinomas with location and prognosis].
    Calli Demirkan N; Tunçyürek M; Ugur Ertan E; Bülent Alkanat M; Içöz G
    Gastroenterol Clin Biol; 2002; 26(6-7):610-5. PubMed ID: 12193861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical importance of histological typing of gastric carcinoma (author's transl)].
    Giedl J
    MMW Munch Med Wochenschr; 1980 Feb; 122(6):205-8. PubMed ID: 6767957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric cancer with special references to WHO and Laurén's classifications: glycogen and triacylglycerol concentrations in the tumor.
    Namiot Z; Stasiewicz J; Szałaj W; Skwarski L; Jodczyk J; Górski J
    Neoplasma; 1989; 36(3):363-8. PubMed ID: 2739816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of p53 expression and cell proliferation in gastric carcinomas. An immunohistochemical study.
    Gonda G; Bajtai A; Nagy P; Szántó I; Kiss J
    Hepatogastroenterology; 2004; 51(55):273-6. PubMed ID: 15011884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between immunoexpression of mucin peptide cores MUC1 and MUC2 and Lauren's histologic subtypes of gastric carcinomas.
    Barresi V; Vitarelli E; Grosso M; Tuccari G; Barresi G
    Eur J Histochem; 2006; 50(4):301-9. PubMed ID: 17213039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gastric carcinoma: a histopathological study of 705 cases].
    Leocata P; Ventura L; Giunta M; Guadagni S; Fortunato C; Discepoli S; Ventura T
    Ann Ital Chir; 1998; 69(3):331-7. PubMed ID: 9835105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
    Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
    Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer: correlation between clinicopathological factors and survival of patients (III).
    Lazăr D; Tăban S; Sporea I; Dema A; Cornianu M; Lazăr E; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2009; 50(3):369-79. PubMed ID: 19690762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histological grading in gastric cancer by Goseki classification: correlation with histopathological subtypes and prognosis.
    Mönig S; Baldus SE; Collet PH; Zirbes TK; Bollschweiler E; Thiele J; Dienes HP; Hölscher AH
    Anticancer Res; 2001; 21(1B):617-20. PubMed ID: 11299815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tenascin expression in gastric cancer with special emphasis on the WHO-, Lauren-, and Goseki-classifications.
    Zirbes TK; Baldus SE; Moenig SP; Schmitz K; Thiele J; Holscher AH; Dienes HP
    Int J Mol Med; 1999 Jul; 4(1):39-42. PubMed ID: 10373635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal type: diffuse type ratio of gastric carcinoma in a Mexican population.
    Mohar A; Suchil-Bernal L; Hernández-Guerrero A; Podolsky-Rapoport I; Herrera-Goepfert R; Mora-Tiscareño A; Aiello-Crocifoglio V
    J Exp Clin Cancer Res; 1997 Jun; 16(2):189-94. PubMed ID: 9261746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology and prognosis of gastric carcinoma: well versus poorly differentiated type.
    Adachi Y; Yasuda K; Inomata M; Sato K; Shiraishi N; Kitano S
    Cancer; 2000 Oct; 89(7):1418-24. PubMed ID: 11013353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic characteristics of replication error-positive gastric carcinoma.
    Kang GH; Yoon GS; Lee HK; Kwon YM; Ro JY
    Mod Pathol; 1999 Jan; 12(1):15-20. PubMed ID: 9950157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated-type gastric carcinomas of stage II and III.
    Shinozaki E; Adachi S; Shoda J; Kawamoto T; Suzuki H; Irimura T; Ohkohchi N
    Int J Oncol; 2004 Nov; 25(5):1257-65. PubMed ID: 15492813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.